Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Pancreatic neuroendocrine tumor

Pancreatic neuroendocrine tumor

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Pancreatic neuroendocrine tumor

6 trials tracked for Pancreatic neuroendocrine tumor.

6Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 4 Phase 1 1 Other / NA 1
  1. Phase 2 AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors Completed
  2. Phase 2 Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer Completed
  3. Phase 2 Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors Completed
  4. Phase 2 RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors Completed
  5. Phase 1 Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Completed
  6. N/A A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Retrospective analysis finds sarcopenia associated with shorter disease-free survival in pancreatic neuroendocrine tumor patients
Oncology Cohort
Retrospective analysis finds sarcopenia associated with shorter disease-free survival in pancreatic neuroendocrine tumor patients Low muscle mass linked to shorter disease-free survival in pancreatic tumor patients
This retrospective cohort study included 86 patients who underwent curative-intent resection for pancreatic neuroendocrine tumors.
Low muscle mass before surgery was linked to shorter disease-free survival in patients with pancreatic neuroendocrine tumors, though this li…
Frontiers Apr 28, 2026